<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diagnostic approach to hypocalcemia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diagnostic approach to hypocalcemia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Diagnostic approach to hypocalcemia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Goltzman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Clifford J Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jean E Mulder, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 30, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hypocalcemia has many causes  (<a class="graphic graphic_table graphicRef62899" href="/z/d/graphic/62899.html" rel="external">table 1</a>). It can result from inadequate parathyroid hormone (PTH) secretion, PTH resistance, vitamin D deficiency or resistance, abnormal magnesium metabolism, and extravascular deposition of calcium, which can occur in several clinical situations. (See  <a class="medical medical_review" href="/z/d/html/840.html" rel="external">"Etiology of hypocalcemia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/5846.html" rel="external">"Etiology of hypocalcemia in infants and children"</a>.)</p><p>The diagnostic approach to hypocalcemia involves confirming, by repeat measurement, the presence of hypocalcemia and distinguishing among the potential etiologies. The diagnosis may be obvious from the patient's history; examples include chronic kidney disease and postsurgical hypoparathyroidism. When the cause is not obvious or a suspected cause needs to be confirmed, other biochemical tests are indicated.</p><p>This topic will review the evaluation of patients with hypocalcemia. The clinical manifestations and treatment of hypocalcemia are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/833.html" rel="external">"Clinical manifestations of hypocalcemia"</a> and  <a class="medical medical_review" href="/z/d/html/826.html" rel="external">"Treatment of hypocalcemia"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">CONFIRM HYPOCALCEMIA</span><span class="headingEndMark"> — </span>The first step in the evaluation of hypocalcemia is to repeat the measurement to confirm that there is a true decrease in the serum calcium concentration: </p><p class="bulletIndent1"><span class="glyph">●</span>In most patients with normal serum albumin concentrations, the total serum calcium concentration can be used for both the initial and the repeat serum calcium measurements. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If the diagnosis of hypocalcemia is in doubt, due to hypoalbuminemia, atypical or absent symptoms, or a minimally reduced serum calcium concentration, we obtain a serum ionized calcium for the repeat measurement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a laboratory known to measure ionized calcium reliably is not available, the total calcium should be repeated and corrected for any abnormality in serum albumin, using a calcium correction formula. (See <a class="local">'Hypoalbuminemia: Calcium correction'</a> below.)</p><p></p><p>Previous values for serum calcium should also be reviewed, if available. If the patient has a low ionized calcium or serum total calcium (corrected for albumin in patients with hypoalbuminemia), further evaluation to identify the cause is indicated. (See <a class="local">'Determining the etiology'</a> below.)</p><p class="headingAnchor" id="H2291314065"><span class="h2">Ionized calcium</span><span class="headingEndMark"> — </span>Ionized calcium remains the gold standard for assessing calcium status because it measures the biologically active (or free) calcium. However, ionized calcium is not performed routinely, because it is more costly and must be handled carefully and stored under appropriate conditions to preserve a sample pH of 7.4. It is important to note that the affinity of calcium for albumin is increased in the presence of alkalosis. Thus, respiratory alkalosis may cause an acute decrease in ionized calcium. (See  <a class="medical medical_review" href="/z/d/html/845.html" rel="external">"Relation between total and ionized serum calcium concentrations", section on 'Acid-base disorders'</a>.)</p><p class="headingAnchor" id="H2618010259"><span class="h2">Hypoalbuminemia: Calcium correction</span><span class="headingEndMark"> — </span>In patients with hypoalbuminemia, the total serum calcium concentration will change in parallel to the albumin concentration and may not accurately reflect the physiologically important ionized (or free) calcium concentration. There are a number of formulas which have been used to correct the total calcium for serum albumin concentrations, but none appears to be universally acceptable when examined for their correlation with ionized calcium. Furthermore, different chemistry laboratories may use different correction formulas.</p><p>Traditionally, one of the most widely utilized equations to estimate the total calcium concentration in clinical practice assumes the serum calcium to fall by 0.8 mg/dL (0.2 mmol/L) for every 1 g/dL (10 g/L) fall in the serum albumin concentration [(<a class="calc calc_professional" href="/z/d/html/13477.html" rel="external">calculator 1</a>) or for standard units (<a class="calc calc_professional" href="/z/d/html/13475.html" rel="external">calculator 2</a>)]. If the measured serum total calcium concentration is 8 mg/dL (2 mmol/L) and the serum albumin concentration is 2 g/dL (20 g/L) below normal, the corrected value will be 9.6 mg/dL (2.4 mmol/L), which is normal. Despite widespread use of this formula in clinical practice over the last several decades, more contemporary studies suggest the accuracy of this estimate is quite poor in a variety of populations, including patients hospitalized with critical illness and patients with advanced-stage chronic kidney disease. (See  <a class="medical medical_review" href="/z/d/html/845.html" rel="external">"Relation between total and ionized serum calcium concentrations", section on 'Hypoalbuminemia'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">DETERMINING THE ETIOLOGY</span><span class="headingEndMark"> — </span>Hypocalcemia has many causes  (<a class="graphic graphic_table graphicRef62899" href="/z/d/graphic/62899.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/840.html" rel="external">"Etiology of hypocalcemia in adults"</a>.)</p><p>The etiology may be obvious from the patient's history and physical examination; examples include chronic kidney disease and postsurgical hypoparathyroidism. When the cause is not obvious or a suspected cause needs to be confirmed, other biochemical tests are indicated. <span class="utd-adt-cnt utd-adt-labi">(Related Lab Interpretation Monograph(s):  <a class="narrative narrative_labi" href="/contents/low-calcium-in-adults?topicRef=837&amp;source=see_link">"Low calcium in adults"</a>.)</span></p><p class="headingAnchor" id="H3188862035"><span class="h2">Clinical clues</span><span class="headingEndMark"> — </span>The etiology of hypocalcemia may be obvious from the clinical history. A family history of hypocalcemia suggests a genetic cause. Chronic familial hypocalcemia is often seen in patients with an activating mutation of the calcium-sensing receptor (autosomal dominant hypocalcemia [ADH] type 1) or, less frequently, of a downstream signaling molecule of the calcium-sensing receptor, GNA11 (ADH type 2), and in pseudohypoparathyroidism. (See  <a class="medical medical_review" href="/z/d/html/838.html" rel="external">"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia"</a>.)</p><p>On the other hand, acquired hypoparathyroidism is most often the result of postsurgical or autoimmune damage to the parathyroid glands. Postsurgical hypoparathyroidism can occur after thyroid, parathyroid, or radical neck surgery for head and neck cancer. Thus, a history of head and neck surgery or the presence of a neck scar suggests postsurgical hypoparathyroidism. (See  <a class="medical medical_review" href="/z/d/html/99737.html" rel="external">"Hypoparathyroidism"</a>.)</p><p>Autoimmune hypoparathyroidism can occur as an isolated abnormality and is also a common feature of polyglandular autoimmune syndrome type I, which is a familial disorder. The presence of chronic mucocutaneous candidiasis and adrenal insufficiency suggests a polyglandular syndrome. (See  <a class="medical medical_review" href="/z/d/html/166.html" rel="external">"Causes of primary adrenal insufficiency (Addison disease)", section on 'Type 1 (monogenic)'</a>.)</p><p>There are several drugs that also may cause hypocalcemia  (<a class="graphic graphic_table graphicRef62899" href="/z/d/graphic/62899.html" rel="external">table 1</a>).</p><p>Other causes of hypocalcemia that may be apparent from the history, physical examination, and routine laboratory data include acute or chronic kidney disease, acute pancreatitis, rhabdomyolysis, and marked increases in tissue breakdown with the release of phosphate from cells, as occurs in the tumor lysis syndrome  (<a class="graphic graphic_table graphicRef62899" href="/z/d/graphic/62899.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/840.html" rel="external">"Etiology of hypocalcemia in adults"</a>.)</p><p>The physical examination may reveal findings of latent tetany, such as Chvostek's and Trousseau's signs, which are strongly suggestive of hypocalcemia. (See  <a class="medical medical_review" href="/z/d/html/833.html" rel="external">"Clinical manifestations of hypocalcemia"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Laboratory evaluation</span><span class="headingEndMark"> — </span>Measurement of serum intact parathyroid hormone (PTH) should be performed in all patients with hypocalcemia; it is the most valuable laboratory test for determining the etiology of hypocalcemia  (<a class="graphic graphic_table graphicRef72080" href="/z/d/graphic/72080.html" rel="external">table 2</a>) [<a href="#rid1">1,2</a>]. (See <a class="local">'Serum PTH concentrations'</a> below.) <span class="utd-adt-cnt utd-adt-labi">(Related Lab Interpretation Monograph(s):  <a class="narrative narrative_labi" href="/contents/low-calcium-in-adults?topicRef=837&amp;source=see_link">"Low calcium in adults"</a>.)</span></p><p>Additional laboratory evaluation to determine etiology may include measurements of serum magnesium, creatinine, phosphate, the vitamin D metabolites calcidiol (25-hydroxyvitamin D [25(OH)D]) and calcitriol (1,25-dihydroxyvitamin D, the active vitamin D hormone), alkaline phosphatase, amylase, and urinary calcium and magnesium excretion [<a href="#rid1">1-4</a>]. These tests should be performed selectively based upon the patient's history and physical examination.</p><p class="headingAnchor" id="H5"><span class="h3">Serum PTH concentrations</span><span class="headingEndMark"> — </span>Serum intact parathyroid hormone (PTH) measurements provide critical information in patients with hypocalcemia but can be interpreted correctly only when serum calcium is measured simultaneously  (<a class="graphic graphic_figure graphicRef50252" href="/z/d/graphic/50252.html" rel="external">figure 1</a>). Hypocalcemia is the most potent stimulus of PTH secretion; as a result, a low or even normal serum PTH concentration in a patient with hypocalcemia is strong evidence of hypoparathyroidism. </p><p>The serum PTH concentration varies with the cause of the hypocalcemia  (<a class="graphic graphic_table graphicRef62899" href="/z/d/graphic/62899.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef72080" href="/z/d/graphic/72080.html" rel="external">table 2</a>) [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Serum PTH is reduced or inappropriately normal in patients with hypoparathyroidism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum PTH is elevated in patients with acute or chronic kidney disease, vitamin D deficiency, and pseudohypoparathyroidism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum PTH is typically normal or low in patients with hypomagnesemia or ADH, a rare disorder characterized by an activating mutation in the calcium-sensing receptor gene or in GNA11.</p><p></p><p class="headingAnchor" id="H6"><span class="h3">Magnesium</span><span class="headingEndMark"> — </span>Hypomagnesemia (serum magnesium concentration below 0.8 mEq/L [1 mg/dL or 0.4 mmol/L]) causes hypocalcemia by inducing PTH resistance or deficiency. (See  <a class="medical medical_review" href="/z/d/html/848.html" rel="external">"Hypomagnesemia: Clinical manifestations of magnesium depletion"</a>.)</p><p>Serum magnesium should be measured in any patient with hypocalcemia in whom the cause is not obvious. Hypocalcemia should resolve within minutes or hours after restoration of normal serum magnesium concentrations if hypomagnesemia was the cause of the hypocalcemia. (See  <a class="medical medical_review" href="/z/d/html/826.html" rel="external">"Treatment of hypocalcemia", section on 'Concurrent hypomagnesemia'</a>.)</p><p>A few patients with magnesium-responsive hypocalcemia have <strong>normal</strong> serum magnesium concentrations. These patients are presumed to have tissue magnesium deficiency. Thus, magnesium supplementation may be indicated in patients with unexplained hypocalcemia who are at risk for hypomagnesemia, such as patients with chronic malabsorption or alcoholism. (See  <a class="medical medical_review" href="/z/d/html/848.html" rel="external">"Hypomagnesemia: Clinical manifestations of magnesium depletion", section on 'Normomagnesemic magnesium depletion'</a>.)</p><p class="headingAnchor" id="H7"><span class="h3">Phosphate</span><span class="headingEndMark"> — </span>Phosphate levels may be elevated, low, or normal depending upon the etiology of hypocalcemia  (<a class="graphic graphic_table graphicRef72080" href="/z/d/graphic/72080.html" rel="external">table 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elevated</strong> – Persistent hypocalcemia and hyperphosphatemia is, in the absence of kidney disease or increased tissue breakdown, virtually diagnostic of either hypoparathyroidism (PTH deficiency) or pseudohypoparathyroidism (PTH resistance). The elevated serum phosphate concentration in patients with either disorder is due to loss of the stimulatory effect of PTH on urinary phosphate excretion and is therefore associated with an inappropriately low fractional excretion of phosphate. (See  <a class="medical medical_review" href="/z/d/html/99737.html" rel="external">"Hypoparathyroidism", section on 'Laboratory findings'</a> and  <a class="medical medical_review" href="/z/d/html/828.html" rel="external">"Overview of the causes and treatment of hyperphosphatemia", section on 'Increased tubular reabsorption of phosphate'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Low</strong> – The presence of a low serum phosphate concentration indicates either excess PTH secretion, which in the context of hypocalcemia means secondary hyperparathyroidism (and some abnormality in vitamin D intake or metabolism), or low dietary phosphate intake, which is uncommon. (See  <a class="medical medical_review" href="/z/d/html/830.html" rel="external">"Hypophosphatemia: Causes of hypophosphatemia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Normal</strong> – Normal serum phosphate in the setting of hypocalcemia may be consistent with hypomagnesemia or mild vitamin D deficiency.</p><p></p><p class="headingAnchor" id="H8"><span class="h3">Vitamin D metabolites</span><span class="headingEndMark"> — </span>Vitamin D deficiency increases PTH secretion by causing hypocalcemia (due to the reduction in intestinal calcium absorption) and, to a lesser degree, by removing the normal inhibitory effect of calcitriol on PTH production [<a href="#rid6">6</a>]. Vitamin D deficiency also diminishes intestinal phosphate absorption. Excess PTH enhances phosphate excretion and lowers the serum phosphate.</p><p>Measurement of serum 25(OH)D (calcidiol) provides more information about vitamin D deficiency than does measurement of serum 1,25-dihydroxyvitamin D (calcitriol) because the hypocalcemia-induced increase in PTH secretion stimulates renal 1,25-dihydroxyvitamin D production (in patients without underlying renal insufficiency). Thus, in individuals with vitamin D deficiency, serum 25(OH)D is low, whereas 1,25-dihydroxyvitamin D is typically normal or high, but it may subsequently decrease because of limited availability of its substrate, 25(OH)D [<a href="#rid7">7</a>]. In contrast, patients with hypoparathyroidism may have normal serum 25(OH)D and low 1,25-dihydroxyvitamin D concentrations  (<a class="graphic graphic_table graphicRef72080" href="/z/d/graphic/72080.html" rel="external">table 2</a>).</p><p>The various causes of vitamin D deficiency usually can be distinguished by the history and other clinical findings (including deficient dietary intake, inadequate sunlight exposure, malabsorption, ingestion of various prescribed drugs [eg, glucocorticoids, antiseizure medications]) and by measurement of 25(OH)D (calcidiol). A more in-depth discussion of the individual disorders can be found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2048.html" rel="external">"Causes of vitamin D deficiency and resistance"</a>.)</p><p class="headingAnchor" id="H2098677745"><span class="h3">Patterns of vitamin D metabolites and phosphate</span><span class="headingEndMark"> — </span>The following patterns in vitamin D metabolites and serum phosphate may be seen in patients with hypocalcemia and secondary increases in PTH and point to different underlying causes of hypocalcemia  (<a class="graphic graphic_table graphicRef72080" href="/z/d/graphic/72080.html" rel="external">table 2</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>A low serum 25(OH)D concentration in a patient with hypocalcemia and hypophosphatemia usually indicates that vitamin D intake or absorption (usually coupled with decreased production in skin) is low. Other possibilities include therapy with antiseizure medications, glucocorticoids, or other drugs [<a href="#rid8">8</a>]; hepatobiliary disease; the nephrotic syndrome (in which vitamin D-binding protein is lost in the urine); or a rare familial disorder characterized by inability to 25-hydroxylate vitamin D in the liver (vitamin D-dependent rickets, type 1B). (See  <a class="medical medical_review" href="/z/d/html/5804.html" rel="external">"Etiology and treatment of calcipenic rickets in children", section on '25-hydroxylase deficiency'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The combination of normal or low serum 25(OH)D concentration and low serum 1,25-dihydroxyvitamin D concentration, with high-normal or elevated serum phosphate, indicates the presence of chronic kidney disease (easily diagnosed from the serum creatinine concentration). Chronic kidney disease is the only condition in which hypocalcemia and secondary hyperparathyroidism are not associated with low or low-normal serum phosphate (as a result of the inability of the diseased kidney to respond to the high PTH).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The combination of normal or low serum 25(OH)D concentration, low serum 1,25-dihydroxyvitamin D concentration, and low serum phosphate suggests the presence of vitamin D-dependent rickets, type 1A (renal 1-alpha-hydroxylase deficiency), also called pseudo-vitamin D deficient rickets.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hereditary vitamin D-resistant rickets (also called vitamin D-dependent rickets, type 2) presents in early childhood and is associated with a defect in the vitamin D receptor. It should be suspected in hypocalcemic patients if serum phosphate is low and serum 1,25-dihydroxyvitamin D concentrations are high. (See  <a class="medical medical_review" href="/z/d/html/5804.html" rel="external">"Etiology and treatment of calcipenic rickets in children", section on 'Hereditary resistance to vitamin D'</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h3">Other</span><span class="headingEndMark"> — </span>Other tests that may be helpful in determining the cause of hypocalcemia include serum alkaline phosphatase, serum amylase, and 24-hour urinary excretion of calcium and magnesium:</p><p class="bulletIndent1"><span class="glyph">●</span>An elevated alkaline phosphatase is common in osteomalacia (as a result of severe vitamin D deficiency and secondary hyperparathyroidism) and can occur with osteoblastic bone metastases, which can cause hypocalcemia due to rapid deposition of calcium in bone metastases [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/2040.html" rel="external">"Clinical manifestations, diagnosis, and treatment of osteomalacia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum amylase is elevated in acute pancreatitis but only slightly in chronic pancreatitis. (See  <a class="medical medical_review" href="/z/d/html/5652.html" rel="external">"Clinical manifestations and diagnosis of acute pancreatitis", section on 'Laboratory findings'</a>.).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low urinary calcium occurs in patients with untreated hypoparathyroidism or vitamin D deficiency. (See  <a class="medical medical_review" href="/z/d/html/99737.html" rel="external">"Hypoparathyroidism", section on 'Laboratory findings'</a> and  <a class="medical medical_review" href="/z/d/html/2022.html" rel="external">"Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of urinary magnesium may be helpful in individuals with hypomagnesemia. In this setting, an elevated value is consistent with renal losses. (See  <a class="medical medical_review" href="/z/d/html/848.html" rel="external">"Hypomagnesemia: Clinical manifestations of magnesium depletion", section on 'Calcium metabolism'</a>.)</p><p></p><p class="headingAnchor" id="H29921892"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/17220.html" rel="external">"Patient education: Hypoparathyroidism (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H10"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirm hypocalcemia </strong>– The first step in the evaluation of hypocalcemia is to repeat the measurement to confirm that there is a true decrease in the serum calcium concentration. In most patients with normal serum albumin concentrations, the total serum calcium concentration can be used for both the initial and the repeat serum calcium measurements. (See <a class="local">'Confirm hypocalcemia'</a> above.)<span class="utd-adt-cnt utd-adt-labi">(Related Lab Interpretation Monograph(s):  <a class="narrative narrative_labi" href="/contents/low-calcium-in-adults?topicRef=837&amp;source=see_link">"Low calcium in adults"</a>.)</span></p><p></p><p class="bulletIndent1">If the diagnosis of hypocalcemia is in doubt, due to hypoalbuminemia, atypical or absent symptoms, or a minimally reduced serum calcium concentration, we obtain a serum ionized calcium. If a laboratory known to measure ionized calcium reliably is not available, the total calcium should be repeated and corrected for the presence of hypoalbuminemia (when present), using a calcium correction formula [(<a class="calc calc_professional" href="/z/d/html/13477.html" rel="external">calculator 1</a>) or for standard units (<a class="calc calc_professional" href="/z/d/html/13475.html" rel="external">calculator 2</a>)]. (See <a class="local">'Ionized calcium'</a> above and <a class="local">'Hypoalbuminemia: Calcium correction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Determining the etiology</strong> – If the patient has a low albumin-corrected serum calcium or ionized calcium concentration, further evaluation to identify the cause is indicated. Hypocalcemia has many causes  (<a class="graphic graphic_table graphicRef62899" href="/z/d/graphic/62899.html" rel="external">table 1</a>). (See <a class="local">'Determining the etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical clues</strong> – The etiology of hypocalcemia may be apparent from history and physical examination. Previous values for serum calcium should also be reviewed, if available. (See  <a class="medical medical_review" href="/z/d/html/840.html" rel="external">"Etiology of hypocalcemia in adults"</a> and <a class="local">'Clinical clues'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory evaluation</strong> – Measurement of serum intact parathyroid hormone (PTH) should be performed in all patients with hypocalcemia; it is the most valuable laboratory test for determining the etiology of hypocalcemia  (<a class="graphic graphic_table graphicRef72080" href="/z/d/graphic/72080.html" rel="external">table 2</a>). (See <a class="local">'Laboratory evaluation'</a> above.)</p><p></p><p class="bulletIndent1">Other measurements that may be helpful include serum magnesium, creatinine, phosphate, vitamin D metabolites (primarily 25-hydroxyvitamin D [25(OH)D]), and alkaline phosphatase. (See <a class="local">'Laboratory evaluation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemia. BMJ 2008; 336:1298.</a></li><li class="breakAll">Shoback D. Hypocalcemia: Definition, etiology, pathogenesis, diagnosis, and management. In: Primer on the metabolic bone diseases and disorders of mineral metabolism, 7th, Rosen CJ (Ed), American Society for Bone and Mineral Research, Hoboken, NJ 2008.</li><li><a class="nounderline abstract_t">Kelly A, Levine MA. Hypocalcemia in the critically ill patient. J Intensive Care Med 2013; 28:166.</a></li><li><a class="nounderline abstract_t">Khan MI, Waguespack SG, Hu MI. Medical management of postsurgical hypoparathyroidism. Endocr Pract 2011; 17 Suppl 1:18.</a></li><li><a class="nounderline abstract_t">Hannan FM, Thakker RV. Investigating hypocalcaemia. BMJ 2013; 346:f2213.</a></li><li><a class="nounderline abstract_t">Komaba H, Kakuta T, Fukagawa M. Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol 2011; 15:797.</a></li><li><a class="nounderline abstract_t">Kruse K. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets. J Pediatr 1995; 126:736.</a></li><li><a class="nounderline abstract_t">Nordqvist O, Lönnbom Svensson U, Brudin L, et al. Adherence to risk management guidelines for drugs which cause vitamin D deficiency - big data from the Swedish health system. Drug Healthc Patient Saf 2019; 11:19.</a></li></ol></div><div id="topicVersionRevision">Topic 837 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18535072" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diagnosis and management of hypocalcaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18535072" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnosis and management of hypocalcaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21841146" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hypocalcemia in the critically ill patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21134871" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Medical management of postsurgical hypoparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23661111" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Investigating hypocalcaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21818548" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Diseases of the parathyroid gland in chronic kidney disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7751997" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30962725" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Adherence to risk management guidelines for drugs which cause vitamin D deficiency - big data from the Swedish health system.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
